There has been an increase in monkeypox cases in 21 countries, including the UK. This has raised concerns about a potential pandemic. However, Pfizer’s chief executive assured that there is no danger of a pandemic.
Sky News has been informed by Pfizer’s chief executive that new COVID variants, which might not be vaccinated, pose a greater threat for global public health than the monkeypox epidemic.
There has been a rise in monkeypox cases in 21 countries, including the UK. However, Albert Bourla stated that it is unlikely to cause a pandemic.
He said, “We were alerted as everyone else when the cases increased, because we didn’t have any cases suddenly, but I’m not concerned right now.”
“We are closely monitoring and watching. This situation is unlikely to be transmissible, so it is very difficult for it become a pandemic. There are vaccines that work. While we are keeping our cool and monitoring the situation closely, I believe that the true problem right now is Covid.
Bourla spoke as he revealed a revolutionary program to offer all Pfizer’s patent-protected drugs at a cost-price to 45 countries with low incomes.
In partnership with German biotech company BioNTech, Pfizer was first to create a coronavirus vaccine that could be used.
Bourla stated that the pandemic highlighted both the importance of the pharmaceutical sector and its larger responsibility.
